I can speak to this only in the sense that what we don't want to do is rob Peter to pay Paul. I think it's important to realize that this is not a zero-sum game for us. We need to fund AMR commensurately, the way we do other really important biomedical and clinical research problems.
I'm not suggesting that we should take money away from other areas to support AMR, but I do think it's important for everyone to realize that we use most of our antibiotics in the hospitals to help cancer patients, for example, and to help patients who undergo cardiovascular surgery. AMR plays a vital role in all of these areas. I think it's just incumbent on society as a whole to understand that this fundamental research is funded in Canada through the CIHR, and that what we want to be able to do is support that to a greater extent than we are right now.